【摘 要】目的：分析厄贝沙坦联合胺碘酮治疗慢性心力衰竭合并室性心律失常的临床疗效。方法：以慢性心力衰竭合并室性心律失常患者100例为研究对象，纳入时间为2016年2月-2018年12月，采用抽签法进行分组，分别为参照组与研究组，每组各50例，给予参照组胺碘酮治疗，给予研究组厄贝沙坦联合胺碘酮治疗。对比两组患者的治疗效果、心率变化、心功能与不良反应，使用统计学进行分析。结果：研究组治疗有效率高于参照组，P<0.05。研究组治疗后心率改善优于参照组，P<0.05。研究组治疗后左室射血分数、左室舒张末径均改善优于参照组，P<0.05。研究组不良反应与参照组比较，P>0.05。结论：对慢性心力衰竭合并室性心律失常患者实施厄贝沙坦联合胺碘酮治疗，有效提高治疗有效率，改善心功能，不良反应少，安全性高，治疗效果显著。

    【关键词】厄贝沙坦;胺碘酮;慢性心力衰竭;室性心律失常

    Abstract： .objective to analyze the clinical efficacy of irbesartan combined with amiodarone in the treatment of chronic heart failure with ventricular arrhythmia. Methods a total of100patients with chronic heart failure complicated with ventricular arrhythmia were selected as the study objects and included from February2016to December2018. They were divided into the reference group and the study group by lot.50patients in each group were treated with histamine iodarone as the reference group and irbersardine combined with amiodarone as the study group. The therapeutic effect ......